NICHOLAS TAYLOR: Open Payments
NPI 1952706624 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 28 payments from 12 companies in 2025. Trend: 2023 $1,734 · 2024 $1,672 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $251 |
| Viatris Specialty LLC | 6 | $202 |
| Novo Nordisk Inc | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 2 | $69 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $50 |
| PFIZER INC. | 2 | $40 |
| United Therapeutics Corporation | 1 | $32 |
| CVRx, Inc. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: DALVANCE, YUPELRI, Ozempic, CAMZYOS, JOURNAVX, ELIQUIS, Orenitram, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
